Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.071 | 0.7 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.062 | 0.7 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |